Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Xandr is a leading advertising technology company that provides a data-driven platform for premium advertising. Originally formed by AT&T through the acquisition of AppNexus, the company specializes in programmatic advertising, offering tools for both buyers (Xandr Invest) and sellers (Xandr Monetize) of digital media. While primarily an adtech firm, Xandr plays a significant role in the healthcare sector by providing HIPAA-compliant data solutions and audience targeting for pharmaceutical and healthcare marketers. The company was acquired by Microsoft in 2021 to bolster its digital advertising and retail media capabilities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Xandr.